Related Experiment Video
Updated: Jul 5, 2025
05:39
Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
844
Targeting Tumor Microenvironment and Metabolism to Overcome Radiation Resistance
Progress in Tumor Research
|January 20, 2024
Summary
The tumor microenvironment, crucial for tumor growth and radiation resistance, involves complex cell and matrix interactions. Targeting these dynamic elements offers new strategies for combined cancer treatment.
Area of Science:
- Oncology
- Cancer Biology
- Radiotherapy Research
Background:
- The tumor microenvironment (TME) is a complex milieu of cells, structural, and functional components.
- Biological processes within the TME, such as vasculature formation and extracellular matrix composition, are vital for tumor progression.
- Tumor heterogeneity arises from dynamic interactions between tumor cells and the stroma, posing a significant challenge to cancer treatment.
Purpose of the Study:
- To provide an overview of the tumor microenvironment's components.
- To elucidate the role of the TME in radiation resistance.
- To discuss potential therapeutic strategies targeting the TME.
Main Methods:
- Review of existing literature on tumor microenvironment composition and function.
- Analysis of the TME's role in response to radiation therapy.
- Identification of critical TME elements and their biological cooperation.
Main Results:
- The TME significantly influences tumor growth, heterogeneity, and resistance to therapy.
- Dynamic changes within the TME occur in response to irradiation.
- Interactions within the TME, including those induced by treatment, are key determinants of tumor aggressiveness.
Conclusions:
- Understanding the TME is essential for comprehending tumor aggressiveness and treatment resistance.
- Targeting critical TME elements presents promising avenues for novel combined treatment modalities with radiotherapy.
- The dynamic and treatment-induced interactions within the TME offer significant therapeutic potential.
Related Concept Videos
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K